First Gene Therapy for Adults with Severe Hemophilia A, BioMarin’s ROCTAVIAN (valoctocogene roxaparvovec), Approved by EC Read more
Sonoma Biotherapeutics Enters Long-Term Lease Agreement to Establish a Treg Cell Therapy R&D and Manufacturing Center Read more
Zerion Pharma and Hovione extend partnership to cover use of the Dispersome technology platform in nutraceuticals Read more
iECURE Receives FDA Rare Pediatric Disease Designation for GTP-506, an Investigational Gene Editing Product Candidate for the Treatment of Ornithine Transcarbamylase (OTC) Deficiency Read more
Alcon to Acquire Aerie Pharmaceuticals, Inc., Enhancing its Ophthalmic Pharmaceutical Portfolio Read more
Thermo Fisher Scientific’s Largest Single-Use Technology Manufacturing Site Opens in Greater Nashville Read more